2Lewelyn CA,Hewitt PE,Knight RS,et al.Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion[J].Lancet,2004,363(9407):417.
3Peden AH,Head MW,Ritchie DL,et al.Preclinical vCLD after blood transfusion in a PRNP codon 129 heterozygous patient[J].Laucet,2004,364(9433):527.
4Houston F,Foster JD,Chong A,et al.Transmission of BSE hy blood transfusion in sheep[J].Lancet,2000,356(9234):999.
5Hunter N,Foster J,Chong A,et al.Transmission of prion disease by blood transfusion[J].J Gen Virol,2002,83(11):2897.
6Petersen LR,Hayes EB.Westward ho? --the spread of West Nile virus[J].N Engl J Med,2004,351:2257-2259.
7Biggerstaff BJ,Petersen LR.Estimated risk of west nile virus transmission through blood transfusion during an epidemic in Queens,New York City[J].Transfusion,2002,42:1019-1026.
8Pealer LN,Marfin AA,Petersen LR,et al.Transmission of west nile virus through blood transfusion in the United States in 2002[J].N Engl J Med,2003,349:1236-1245.
9Stramer SL,Fang CT,Foster GA,et al.West nile virus among blood donors in the United States,2003 and 2004[J].N End J Med,2005,353:451-459.
10Tsetsarkin KA,Vanlandingham DL,McGee CE,et al.A single mutation in chikungunya virus affects vector specificity and epidemic potential[J].Plo S Pathog,2007,3:201.
4Pellegrin I, Garrigue I, Ekouevi D, et al. New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients. J Infect Dis, 2000, 182(1):36
5Boeckh M,Gallez-Hawkins GM, Myerson D, et al. Plasma polymerase chain reaction for cytomegalorivus and afte allogeneic marrow transplantation. Transplantation, 1997, 64(1):108
6Barrett-muir W,Breuer J, Millar C, et al. CMV viral load measurements in whole blood and plasma-which is best following renal transplantation? Transplantation, 2000, 70(1):116
7Gerna G, Baldanti F, Middeldorp JM, et al. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung and bone marrow transplant recipients as determined by nucleic acid sequenced-based amplification. J Clin Microbiol, 1999, 37(4):902
8Gerna G, Baldanti F, Lilleri D, et al. Human cytomegalovirus immediate early mRNA detection by nucleic acid sequenced-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients. J Clin Microbiol, 2000, 38(5):1845
9Gerna G, Baldanti F, Lilleri D, et al. Human cytomegalovirus pp67mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients:a prospective randomized controlled open-label trial. Transplantation, 2003, 75(7):1012
10van der Bij W, Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin Infect Dis, 2001, 33(Suppl 1): S33
1Anglemyer A, Agrawal AK, Rutherford GW, et al. Treatment of Ka- posi sarcoma in children with HIV-1 infection [ J ]. Cochrane Data- base Syst Rev,2014,1 ( 1 ) :9826 -9827.
2Leao JC, de Faria AB, Fonseca DD, et al. Intrahost genetic variability of human herpes virus-8 [ J ]. J Med Viro1,2013,85 (4) :636 - 645.
